Intelligence Platform
Patents
Browse 12 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11986534
Treatment of anthrax with pegylated capsule-degrading enzyme
granted patentUS 11878064
Nanoparticle/peptide method of blocking potassium channels
granted patentUS 11786601
Pegylated capsule-degrading enzyme for the treatment of anthrax
granted patentUS 11744834
Metal-porphyrin complexes for the inactivation of the biological activity of opioids
granted patentUS 11739137
Single domain antibodies to SARS-CoV-2 nucleocapsid protein
granted patentUS 11617800
Nanoparticle-enhanced activity of a potassium channel-blocking peptide
granted patentUS 11542320
Nucleic acids encoding single domain antibodies to chikungunya virus
granted patentUS 11028152
Single domain antibodies to Chikungunya virus
granted patentUS 10898583
Harnessing quantum dots to study, visualize, and promote immune tolerance
granted patentUS 10793865
Transferrable mechanism of generating inducible, BAR domain protein-mediated bacterial out
granted patentUS 10780185
Multifunctional nanoparticle bioconjugates for photoacoustic-based recording of cellular m
granted patentUS 10183080
Use of single dendritic wedge cell penetrating peptides to facilitate cellular delivery of
granted